Beta-adrenergic receptors on polymorphonuclear cell membranes in essential hypertension. 1985

H E Eliahou, and I Serban, and S Gavendo, and S Kapuler, and Z Farfel, and A Iaina

Beta adrenergic receptor binding sites were determined and characterized by specific binding of (+/-)[125I] iodocyanopindolol to membranes obtained from circulating polymorphonuclear leukocytes. No difference was found in the number of receptor sites and in their dissociation constants (Kd) between patients with untreated essential hypertension (EH), EH treated with drugs other than beta blockers, and in normotensive controls. The group with EH receiving treatment with beta blockers had a significantly higher receptor density and Kd as compared with all the other groups (p less than 0.05). It is concluded that the beta-adrenergic system of patients with essential hypertension at the receptor level is not different from normotensive subjects and responds to beta blockers by up-regulation.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D010869 Pindolol A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638) Prindolol,LB-46,Visken,LB 46,LB46
D011943 Receptors, Adrenergic, beta One of two major pharmacologically defined classes of adrenergic receptors. The beta adrenergic receptors play an important role in regulating CARDIAC MUSCLE contraction, SMOOTH MUSCLE relaxation, and GLYCOGENOLYSIS. Adrenergic beta-Receptor,Adrenergic beta-Receptors,Receptors, beta-Adrenergic,beta Adrenergic Receptor,beta-Adrenergic Receptor,beta-Adrenergic Receptors,Receptor, Adrenergic, beta,Adrenergic Receptor, beta,Adrenergic beta Receptor,Adrenergic beta Receptors,Receptor, beta Adrenergic,Receptor, beta-Adrenergic,Receptors, beta Adrenergic,beta Adrenergic Receptors,beta-Receptor, Adrenergic,beta-Receptors, Adrenergic
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

H E Eliahou, and I Serban, and S Gavendo, and S Kapuler, and Z Farfel, and A Iaina
October 1978, The New England journal of medicine,
H E Eliahou, and I Serban, and S Gavendo, and S Kapuler, and Z Farfel, and A Iaina
October 1992, Acta paediatrica Japonica : Overseas edition,
H E Eliahou, and I Serban, and S Gavendo, and S Kapuler, and Z Farfel, and A Iaina
July 1983, Biochemical pharmacology,
H E Eliahou, and I Serban, and S Gavendo, and S Kapuler, and Z Farfel, and A Iaina
March 1981, Research communications in chemical pathology and pharmacology,
H E Eliahou, and I Serban, and S Gavendo, and S Kapuler, and Z Farfel, and A Iaina
May 1987, Casopis lekaru ceskych,
H E Eliahou, and I Serban, and S Gavendo, and S Kapuler, and Z Farfel, and A Iaina
December 1986, Journal of hypertension. Supplement : official journal of the International Society of Hypertension,
H E Eliahou, and I Serban, and S Gavendo, and S Kapuler, and Z Farfel, and A Iaina
February 1985, Vnitrni lekarstvi,
H E Eliahou, and I Serban, and S Gavendo, and S Kapuler, and Z Farfel, and A Iaina
March 1980, The Journal of clinical investigation,
H E Eliahou, and I Serban, and S Gavendo, and S Kapuler, and Z Farfel, and A Iaina
November 1979, Life sciences,
H E Eliahou, and I Serban, and S Gavendo, and S Kapuler, and Z Farfel, and A Iaina
December 1987, Activitas nervosa superior,
Copied contents to your clipboard!